
-
2014
Company Description
Autolus is a private biopharmaceutical company, focused on the development and commercialisation
The Autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered T-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. They are building a leading biotechnology company focussed on the development and commercialisation of engineered T-cell therapies for haematological and solid tumours. Autolus has the ambition to be a leader of a revolution in medicine in which life-threatening diseases are treated by a patient’s own ce
-
Manufacturer:
Science and Engineering -
Formed:
2014 -
Company Website:
-
Company E-mail:
-
Company Address:
Autolus Limited Forest House 58 Wood Lane, White CityUnited KingdomLondon -
CEO:
- Edward Hodgkin
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits